Evidence map›Paper›PMID 38449285›Full record

ArticleBioinformatics (Oxford, England)2024

iNGNN-DTI: prediction of drug-target interaction with interpretable nested graph neural network and pretrained molecule models.

Yan Sun, Yan Yi Li, Carson K Leung, Pingzhao Hu

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Interpretable Multimodal Molecular Language Model for Drug-Target Interaction Prediction.Interdisciplinary sciences, computational life sciences · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yan SunDepartment of Biochemistry, Western University, London, ON, N6G 2V4, Canada.
Yan Yi LiDivision of Biostatistics, University of Toronto, Toronto, ON, M5T 3M7, Canada.ORCID 0009-0004-9174-1396
Carson K LeungDepartment of Computer Science, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.ORCID 0000-0002-7541-9127
Pingzhao HuDepartment of Biochemistry, Western University, London, ON, N6G 2V4, Canada.ORCID 0000-0002-9546-2245
Western University · CAUniversity of Manitoba · CAUniversity of Toronto · CA

Funding

Canadian Institute of Health Research PLL 185683Natural Sciences and Engineering Research Council of Canada RGPIN-2021-04072
6 · The paper itself

Abstract

motivationDrug-target interaction (DTI) prediction aims to identify interactions between drugs and protein targets. Deep learning can automatically learn discriminative features from drug and protein target representations for DTI prediction, but challenges remain, making it an open question. Existing approaches encode drugs and targets into features using deep learning models, but they often lack explanations for underlying interactions. Moreover, limited labeled DTIs in the chemical space can hinder model generalization.

resultsWe propose an interpretable nested graph neural network for DTI prediction (iNGNN-DTI) using pre-trained molecule and protein models. The analysis is conducted on graph data representing drugs and targets by using a specific type of nested graph neural network, in which the target graphs are created based on 3D structures using Alphafold2. This architecture is highly expressive in capturing substructures of the graph data. We use a cross-attention module to capture interaction information between the substructures of drugs and targets. To improve feature representations, we integrate features learned by models that are pre-trained on large unlabeled small molecule and protein datasets, respectively. We evaluate our model on three benchmark datasets, and it shows a consistent improvement on all baseline models in all datasets. We also run an experiment with previously unseen drugs or targets in the test set, and our model outperforms all of the baselines. Furthermore, the iNGNN-DTI can provide more insights into the interaction by visualizing the weights learned by the cross-attention module. AVAILABILITY AND IMPLEMENTATION: The source code of the algorithm is available at https://github.com/syan1992/iNGNN-DTI.

Indexed as

AlgorithmsNeural Networks, ComputerDrug Delivery SystemsDrug Interactions

Identifiers

PMID38449285
PMCPMC10957515
OpenAlexW4392564168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.